First Report of Dermatomyositis-Associated Panniculitis in Ovarian Adenocarcinoma

Share this content:

(ChemotherapyAdvisor) – In what is believed to be the first reported case of dermatomyositis-associated panniculitis in the setting of ovarian adenocarcinoma and a recurrent malignancy, a 63-year-old woman sustained clinical improvement following treatment with prednisone and oral methotrexate, investigators reported in Archives of Dermatology online March 19.

Panniculitis, a rare cutaneous manifestation of dermatomyositis, was first reported in the literature in 1924; since then, only about 20 additional cases have been reported. This paucity of data has limited understanding of the true significance, prognostic implications, and management of this disease, which commonly presents as tender, erythematous subcutaneous nodules on the thighs, arms, and buttocks that can progress to form calcifications and lipoatrophy.

Presentation of panniculitis can be prior to, concurrent with, or subsequent to symptoms of dermatomyositis. The literature suggests onset ranges from 14 months preceding a diagnosis of dermatomyositis to five years afterwards.

“Given its rarity, it is difficult to ascertain the clinical significance of panniculitis associated with malignancy and dermatomyositis, and we are unable to make generalizations based on this single case,” the investigators noted. “However, further study and accumulation of case data may help to decipher the potential prognostic significance as well as the most beneficial therapeutic regimens.”


Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs